Verrutop now available from Espère Healthcare
For Podiatry, Dermatology and Sexual Health Clinics
For more information or to order direct please call 01462 346100 or email info@esperehealth.co.uk
Click Here to buy online direct
Resources
Appointment Cards
- Included with every pack
- Information with what to expect with treatment
Product Leaflets
- Patient information leaflets
- Free on request with orders
Clinic Posters
- Available to display treatment options
- Free on request with orders
Product Videos
- For use on social media
- Can be customised on request
Verrutop, the revolution in topical treatment for difficult warts
Verrutop is a topical solution for professional use providing painless treatment of difficult warts that is highly effective in just a few applications.
With Nitrizinc Complex:
A unique, elevated combination
- Nitric acid
- Organic acids
- Zn and Cu salts
*As sensitivity varies, some patients may experience a slight, short-lived tingling after application of the product. This disappears after a few seconds.
Use under medical supervision
Class IIA Healthcare Product
4 ampoules 100 μll Nitrizinc Complex®
Applicator capillaries
Instruction booklet
How do you apply Verrutop?
Verrutop is easy and quick to apply. It doesn’t require any special equipment and doesn’t affect the patient’s daily life.
Break the ampoule
Insert the capillary
to extract Verrutop®
Fill the applicator
with the product
Apply the product
with the capillary directly on the wart
Apply the necesary quantity of product to cover the wart according to its size but always avoid excess. If re-application is necessary wait 15 to 30 seconds between applications. The patient must be assessed by a health professional after a minimum period of 1 to 2 weeks, depending on the location to evaluate elimination of the wart or to re-apply the product if necessary. Treatment could be repeated for up to a maximum of six sessions, separated by a minimum period of 7 days. Check the product information leaflet for further information and warnings.
See how to eliminate verrucas with Verrutop® with Dr Ogalla. See video
Quick and painless* application
One applied to the warts, it produces a painless mummification of the damaged tissue that causes the wart to detach automatically as healthy skin forms.
Proven efficacy,
even in the most difficult cases
90%
of patients cured after a maximum of 6 treatment sesions1. Average: 3 sessions .
87%
of patients cured after a maximum of 4 treatment sessions2. 49% of them cured after only one session
Efficacy in palmoplantar warts resistant to cryotherapy3
72%
responded totally or partially to treatment with Verrutop®
% cured plantar warts
59%
disappeared after 1-3 applications of Verrutop®
Number of applications
With Verrutop, the complete viral DNA elimination occurs in 40% of cases,
while no effect was achieved by liquid nitrogen4
Bibliografía
*. Verrutop in general is a painless treatment , altough some people may experience some temporary discomfort thatranges from a burning to slight tenderness or pain. 1. Galloni C, Balice Y, Fachetti M, Marchetti S, Motta L, Pisacane D. Efficacy and tolerability assessment of a new medical device containing a nitric-zinc complex to treat palmar, plantar and periungual warts: experience with 210 patients. Poster session presented at 27th EADV Congress; 2018 Sep 12-16; France, Paris. 2. Ciccarese G. Efficacy Assessment of a Topically Applied Nitric–Zinc Complex Solution for the Treatment of External Anogenital Warts in 100 Patients. Dermatol Ther (Heidelb). 2019 Jun;9(2):327-335 3. . Guillet G, Jéroche F. Evaluation de l’efficacité et de la tolérance d’un traitement de verrues palmo-plantaires après échec thérapeutique avec cryothérapie, et de verrues péri-unguéales. Poitiers, France, Dermatologie pratique N°363-octobre 2012, p.9-10. 4. Viennet C et al. Assessment of the efficacy of a new formulation for plantar wart mummification: new experimental design and human papillomavirus identification .CED a 2012 British Association of Dermatologists Clinical and Experimental Dermatology, 38, 85–88